Similar articles

• Pharmacology and clinical use of hydralazine in the treatment of diastolic hypertension.

  SCHIRGER A, SPITTELL JA Jr. SCHIRGER A, et al. Am J Cardiol. 1962 Jun;9:854-9. doi: 10.1016/0002-9149(62)90209-6. Am J Cardiol. 1962. PMID: 14498465 No abstract available.
• Prolonged hydralazine hydrochloride administration in 132 hypertensive patients--Study of toxicity.

  PIGEON G, GENEST J. PIGEON G, et al. Can Med Assoc J. 1960 Oct 1;83(14):743-6. Can Med Assoc J. 1960. PMID: 13735669 Free PMC article. No abstract available.
• Effect of the addition of hydralazine or chlorothiazide to ganglionic blocking agents in the treatment of severe hypertension.

  BLAQUIER P, HOOBLER SW. BLAQUIER P, et al. Am J Med Sci. 1959 Dec;238:740-6. doi: 10.1097/00000441-195912000-00009. Am J Med Sci. 1959. PMID: 13801343 No abstract available.
• The use of syrosingopine (SU-3118) and hydralazine in ambulatory hypertensive patients.

  DUNSMORE RA, DUNSMORE LD, ELIAS M. DUNSMORE RA, et al. Am J Med Sci. 1960 Feb;239:148-53. doi: 10.1097/00000441-196002000-00004. Am J Med Sci. 1960. PMID: 13818707 No abstract available.
• [Results in the therapy of hypertension with reserpine, dihydrazinophthalazine, a combination of both and placebos].

  BENGOLEA A, BASTAROLI J. BENGOLEA A, et al. Prensa Med Argent. 1959 Jul 3;46:1701-6. Prensa Med Argent. 1959. PMID: 13798865 Spanish. No abstract available.